As of mid-August 2026, the CDC has confirmed 2,566 U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and cases reported in 47 jurisdictions. Sustained transmission in under-vaccinated communities, particularly children under 19, is driving the surge, consistent with historical patterns where MMR coverage below 95% enables rapid spread given the virus’s basic reproduction number of 12–18. Official surveillance shows most infections linked to domestic chains rather than new imports, raising elimination-status concerns. Weekly CDC updates and school-year transmission data through December will provide key signals for final 2026 totals.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоСлучаи кори в США в 2026 году?
Случаи кори в США в 2026 году?
$7,837,756 Объем
$7,837,756 Объем
31 дек. 2026 г.
↑4,5 тыс.
54%
↑3к
97%
↑3,5 тыс.
95%
↑4k
80%
↑5к
35%
↑7,5 тыс.
12%
↑10k
6%
↑12,5 тыс.
5%
$7,837,756 Объем
$7,837,756 Объем
31 дек. 2026 г.
↑4,5 тыс.
$22 Объем
54%
↑3к
$90,832 Объем
97%
↑3,5 тыс.
$13,859 Объем
95%
↑4k
$224,881 Объем
80%
↑5к
$231,096 Объем
35%
↑7,5 тыс.
$185,225 Объем
12%
↑10k
$6,516,157 Объем
6%
↑12,5 тыс.
$349,917 Объем
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and cases reported in 47 jurisdictions. Sustained transmission in under-vaccinated communities, particularly children under 19, is driving the surge, consistent with historical patterns where MMR coverage below 95% enables rapid spread given the virus’s basic reproduction number of 12–18. Official surveillance shows most infections linked to domestic chains rather than new imports, raising elimination-status concerns. Weekly CDC updates and school-year transmission data through December will provide key signals for final 2026 totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Feb 16, 2026, 11:51 AM ET
Объем
$7,837,756Дата окончания
31 дек. 2026 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and cases reported in 47 jurisdictions. Sustained transmission in under-vaccinated communities, particularly children under 19, is driving the surge, consistent with historical patterns where MMR coverage below 95% enables rapid spread given the virus’s basic reproduction number of 12–18. Official surveillance shows most infections linked to domestic chains rather than new imports, raising elimination-status concerns. Weekly CDC updates and school-year transmission data through December will provide key signals for final 2026 totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$7,837,756Дата окончания
31 дек. 2026 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, the CDC has confirmed 2,566 U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and cases reported in 47 jurisdictions. Sustained transmission in under-vaccinated communities, particularly children under 19, is driving the surge, consistent with historical patterns where MMR coverage below 95% enables rapid spread given the virus’s basic reproduction number of 12–18. Official surveillance shows most infections linked to domestic chains rather than new imports, raising elimination-status concerns. Weekly CDC updates and school-year transmission data through December will provide key signals for final 2026 totals.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы